New pill for postpartum depression a vital breakthrough

New pill for postpartum depression a vital breakthrough
One in seven new mothers develop the serious medical condition. (Image: Getty)
Bloomberg
By Lisa Jarvis The landmark approval in the US of the first pill for postpartum depression offers an important new treatment for the 1 in 7 new mothers who develop the condition. Suicide is a leading cause of maternal mortality in the US. And yet on its own, the new drug – promising as it is – isn’t enough. Consider that as many as half of women with postpartum depression go undiagnosed.Nonetheless, the new pill is a remarkable breakthrough, and one of several encouraging recent developments in women’s health &...

More Health

Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

Gregor Thompson 16 Sep 2025
F&P Healthcare urges Govt to shut patent loophole
Markets

F&P Healthcare urges Govt to shut patent loophole

The company says the current patent loophole threatens its NZ operations.

Michael Neilson 16 Sep 2025
F&P Healthcare one step closer to new Karaka campus
Policy

F&P Healthcare one step closer to new Karaka campus

Auckland Council has approved a request to rezone nearly 90ha going to hearings.

Oliver Lewis 12 Sep 2025
How RFK Jnr's Medicare reform could aid this NZ firm
Markets

How RFK Jnr's Medicare reform could aid this NZ firm

'Wild west' conditions hampered its US push. They could be changing.